Cargando…

Gadolinium Complexes as Contrast Agent for Cellular NMR Spectroscopy

Aqua Gd(3+) and Gd-DOTA (gadolinium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacete) complexes were studied as a contrast agent in cellular NMR (nuclear magnetic resonance) spectroscopy for distinguishing between intracellular and extracellular spaces. The contrast agents for this purpose should...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sakol, Nat, Egawa, Ayako, Fujiwara, Toshimichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312942/ https://www.ncbi.nlm.nih.gov/pubmed/32516957 http://dx.doi.org/10.3390/ijms21114042

Ejemplares similares

Gadolinium contrast agents: Over exposure?
por: Biederman, Robert W, et al.
Publicado: (2016)

Gadolinium-DTPA: A New Contrast Agent
por: Niendorf, H. P.
Publicado: (1988)

Peptide-Based Soft Hydrogels Modified with Gadolinium Complexes as MRI Contrast Agents
por: Gallo, Enrico, et al.
Publicado: (2020)

Linear Gadolinium-Based Contrast Agents Are Associated With Brain Gadolinium Retention in Healthy Rats
por: Robert, Philippe, et al.
Publicado: (2016)

Gadolinium deposition in the brain of dogs after multiple intravenous administrations of linear gadolinium based contrast agents
por: Richter, Henning, et al.
Publicado: (2020)

The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review
por: Olchowy, Cyprian, et al.
Publicado: (2017)

Biocompatible Polyhydroxyethylaspartamide-based Micelles with Gadolinium for MRI Contrast Agents
por: Jeong, Sang Young, et al.
Publicado: (2010)

Immediate reaction to gadolinium based contrast agent with fatal outcome()()()
por: Behzadi, Ashkan Heshmatzadeh, et al.
Publicado: (2018)

Gadolinium-Based Contrast Agents Hypersensitivity: A Case Series
por: Nucera, Eleonora, et al.
Publicado: (2021)

Gadolinium-based contrast agents in neurofibromatosis type 1 (Review)
por: Năstase, Florentina, et al.
Publicado: (2021)

Recent Advances in Gadolinium Based Contrast Agents for Bioimaging Applications
por: Fatima, Atiya, et al.
Publicado: (2021)

Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T(1) contrast
por: Ananta, Jeyarama S., et al.
Publicado: (2010)

Gadolinium retention within multiple rat organs after intra-articular administration of gadolinium-based contrast agents
por: Ringler, Michael D., et al.
Publicado: (2021)

Gadolinium Retention in the Brain of Mother and Pup Mouse: Effect of Pregnancy and Repeated Administration of Gadolinium‐Based Contrast Agents
por: Yao, Xiang, et al.
Publicado: (2022)

PEG-modified gadolinium nanoparticles as contrast agents for in vivo micro-CT
por: Cruje, Charmainne, et al.
Publicado: (2021)

The Role of Ferrous Ion in the Effect of the Gadolinium-Based Contrast Agents (GBCA) on the Purkinje Cells Arborization: An In Vitro Study
por: Kartamihardja, Achmad Adhipatria Perayabangsa, et al.
Publicado: (2021)

Thermal Excitation of Gadolinium-Based Contrast Agents Using Spin Resonance
por: Dinger, Steven C., et al.
Publicado: (2016)

Investigating the Impact of Gadolinium-Based Contrast Agents on the Corrected QT Interval
por: Gress, Kyle L, et al.
Publicado: (2020)

Formation of gadolinium–ferritin from clinical magnetic resonance contrast agents
por: Neburkova, Jitka, et al.
Publicado: (2020)

Acute respiratory distress syndrome after the use of gadolinium contrast agent
por: Kerget, Bugra, et al.
Publicado: (2018)

The New Restrictions on the Use of Linear Gadolinium-based Contrast Agents in Japan
por: Kanda, Tomonori
Publicado: (2018)

Effect of different doses of gadolinium contrast agent on clinical outcomes in MS
por: Ackermans, Nathalie, et al.
Publicado: (2019)

Gadolinium as a contrast agent for infusion sialograms in patients with iodine allergy
por: Sabotin, Ryan P., et al.
Publicado: (2023)

Analytical Interference in Serum Iron Determination Reveals Iron Versus Gadolinium Transmetallation With Linear Gadolinium-Based Contrast Agents
por: Fretellier, Nathalie, et al.
Publicado: (2014)

A risk prediction model for contrast-induced nephropathy associated with gadolinium-based contrast agents
por: Zheng, Huanhuan, et al.
Publicado: (2022)

Gadolinium(III) Complexes with N-Alkyl-N-methylglucamine Surfactants Incorporated into Liposomes as Potential MRI Contrast Agents
por: Silva, Simone Rodrigues, et al.
Publicado: (2015)

Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms
por: Rogosnitzky, Moshe, et al.
Publicado: (2016)

Gadolinium contrast agents- challenges and opportunities of a multidisciplinary approach: Literature review
por: Iyad, Nebal, et al.
Publicado: (2023)

New Dual Mode Gadolinium Nanoparticle Contrast Agent for Magnetic Resonance Imaging
por: Ghaghada, Ketan B., et al.
Publicado: (2009)

Gadolinium: pharmacokinetics and toxicity in humans and laboratory animals following contrast agent administration
por: Davies, Julie, et al.
Publicado: (2022)

Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents
por: Lohrke, Jessica, et al.
Publicado: (2017)

Single- and Multi-Arm Gadolinium MRI Contrast Agents for Targeted Imaging of Glioblastoma
por: Patil, Rameshwar, et al.
Publicado: (2020)

Revisiting the risks of MRI with Gadolinium based contrast agents—review of literature and guidelines
por: Khawaja, Aurang Z., et al.
Publicado: (2015)

The benefits and side effects of gadolinium-based contrast agents in multiple sclerosis patients
Publicado: (2022)

Gadolinium‐based contrast agent exposures and physical and cognitive disability in multiple sclerosis
por: Nakamura, Kunio, et al.
Publicado: (2022)

Gadolinium-Based Paramagnetic Relaxation Enhancement Agent Enhances Sensitivity for NUS Multidimensional NMR-Based Metabolomics
por: Honrao, Chandrashekhar, et al.
Publicado: (2021)

Quantification and Assessment of the Chemical Form of Residual Gadolinium in the Brain After Repeated Administration of Gadolinium-Based Contrast Agents: Comparative Study in Rats
por: Frenzel, Thomas, et al.
Publicado: (2017)

Controlled intracellular self-assembly of gadolinium nanoparticles as smart molecular MR contrast agents
por: Cao, Chun-Yan, et al.
Publicado: (2013)

Gadolinium-doped fluorescent carbon quantum dots as MRI contrast agents and fluorescent probes
por: Molaei, Mohammad Jafar
Publicado: (2022)

Macrocyclic MR contrast agents: evaluation of multiple-organ gadolinium retention in healthy rats
por: Bussi, Simona, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f7am973hmsjsf2d36tc8cda7es